| Article Dump |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Diseases > The Basics about Bird Flu |
|
Article Dump - The Basics about Bird Flu
Avian influenza is a natural infection in wild birds, which are actually carriers without ever being affected by the dise According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ase. Never the less, the avian flu can be passed to domestic poultry through various types of contact such as sharing the ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in same food and water or coming in contact with excrements and cages of contaminated birds. A fairly easy way of determinin lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. whether poultry such as chicken, ducks, turkeys has bird flu is microscope examination of their saliva and nasal secreti here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ns. Bird flu caused by influenza A viruses does not have a spontaneous effect on humans. The possibility is rather low t d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro many because we are not as susceptible to it as birds. Though rare, cases of human infection have been outlined by the p ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ess. The virus that spreads among humans is known as the human influenza virus and has three branches: H1N1, H1N2, H3N2. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi he viruses vary through the different types of proteins that form their genetic coat: Hemagglutinin and Neuraminidaze. Pa nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ts of the virus affecting humans have also been found in birds, but the main concern is that the virus is in permanent re and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ lication and may one day evolve into a more potent form. Furthermore, there are two forms of influenza, differing throug ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi pathogenic capacity. The low form is usually not easily spotted and can cause minor derangements, while the high extreme ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a of virulence are much more dangerous leading to high death ratio and damaging vital body parts. Moreover, the H5N1 viru dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod or the influenza A virus has affected a number of people. For this reason, it is becoming a nuisance in undeveloped regi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ns of Asia and Africa where poverty is widespread and living conditions are at a limit. In these places transmission betw tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen en different species of birds and bird to human transmission is very likely because people live in very close contact wit t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel their poultry. Generally the following manifestations are present: conjunctivitis, pneumonia, breathing disorder, fever, ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust cough, sore throat, muscle aches. Although researchers are trying to come up with a vaccine as fast as possible, further y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products experiments with the genetic coat of the virus are a must for the cure to be efficient. However, medication does exist. T . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de e likes of Zanamavir and Oseltamavir are currently on the market but it is not known whether they work or not. At presen elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip time nobody can tell 100% if bird flu can cause a pandemic, but the H5N1 virus is closely monitored by experts worldwide tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Prepaid SIM Cards for Thailand Wedding Gifts – Wanted and Unwanted San Francisco Culinary Arts Academy
|